Intervention
Zinc
Last updated Sat May 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
RCT evidence— AMD (AREDS2), common cold (Cochrane meta-analyses)
Why it matters
Zinc is a cofactor for over 300 enzymes including DNA repair (PARP, BRCA1 interaction), antioxidant defence (SOD), insulin storage, taste perception, and innate + adaptive immune function. Population deficiency is common in older adults due to reduced absorption and dietary changes.
Evidence-based uses
- AMD progression: zinc 80 mg + copper 2 mg (AREDS2 formula) slows progression of intermediate to advanced AMD.
- Common cold duration: zinc lozenges (especially acetate) within 24 hours of onset reduce duration by ~1.5 days.
- Acne: oral zinc moderate evidence; topical clearer.
- Wilson disease, sickle cell: clinical-indication use.
The copper trade-off
Chronic high-dose zinc (>40 mg/day) blocks copper absorption, causing sideroblastic anaemia and myelopathy in case reports. Long-term zinc supplements should include ~1–2 mg copper.
Cautions
- Interferes with absorption of iron, calcium, fluoroquinolone and tetracycline antibiotics.
- Intranasal zinc has caused permanent anosmia; do not use.
- High doses cause nausea and may suppress immunity (the opposite of desired effect).
Related entries
References
- AREDS2 Research Group. Lutein/zeaxanthin and omega-3 fatty acids for AMD (AREDS2). JAMA 309, 2005–2015 (2013).